J. Burton

发表

Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer

C. Rodriguez, R. Rebhun, S. Stanley, 2015, Journal of veterinary internal medicine.

Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma.

K. Woolard, R. Rebhun, R. Laufer-Amorim, 2019, Veterinary and comparative oncology.

Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma.

S. Dow, J. Burton, A. Guth, 2010, Journal of veterinary internal medicine.

Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991-2014).

P. Mayhew, B. Séguin, M. Martano, 2018, Journal of the American Veterinary Medical Association.

Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study

J. Stern, J. Burton, K. Skorupski, 2020, Frontiers in Veterinary Science.

Comparison of Carboplatin and Doxorubicin‐Based Chemotherapy Protocols in 470 Dogs after Amputation for Treatment of Appendicular Osteosarcoma

D. Thamm, S. Withrow, S. Lana, 2014, Journal of veterinary internal medicine.

Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.

D. Thamm, E. Garrett-Mayer, J. Burton, 2013, Veterinary and comparative oncology.

MRI characteristics of canine prostatic neoplasia.

R. Rebhun, M. Kent, J. Burton, 2022, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response

S. Stewart, K. Woolard, R. Rebhun, 2022, Journal for ImmunoTherapy of Cancer.

Patient characteristics, prognostic factors and outcome of dogs with high‐grade primary mediastinal lymphoma

R. Rebhun, W. Vernau, J. Burton, 2018, Veterinary and comparative oncology.

Expression of Phosphorylated KIT in Canine Mast Cell Tumor

D. Thamm, D. Gustafson, A. Avery, 2017, Veterinary pathology.

Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma

D. Thamm, D. Vail, J. Burton, 2014, Journal of veterinary internal medicine.

Lower urinary tract transitional cell carcinoma in cats: Clinical findings, treatments, and outcomes in 118 cases

P. Mayhew, R. Rebhun, M. Giuffrida, 2019, Journal of veterinary internal medicine.

Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.

D. Thamm, D. Vail, J. Burton, 2013, The Journal of small animal practice.

Lymph Nodes

Paul R. Avery, L. Aresu, S. Comazzi, 2020, Veterinary Cytology.

Clinical presentation, treatment and outcome in 31 dogs with presumed primary colorectal lymphoma (2001–2013)†

A. Di Bella, J. Burton, O. Kristal, 2017, Veterinary and comparative oncology.

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

D. Thamm, D. Vail, A. Avery, 2015, Journal of veterinary internal medicine.

Flow Cytometric Characterization and Clinical Outcome of CD4+ T‐Cell Lymphoma in Dogs: 67 Cases

Paul R. Avery, D. Seelig, P. Morley, 2014, Journal of veterinary internal medicine.

Clinical outcome and Ki67 evaluation in dogs with nodal small cell B‐cell lymphoma diagnosed by flow cytometry

A. Avery, J. Burton, K. L. Hughes, 2022, Journal of veterinary internal medicine.

Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma

R. Rebhun, S. Al-Nadaf, J. Burton, 2018, BMC Veterinary Research.

Chemotherapy effectiveness and mortality prediction in surgically treated osteosarcoma dogs: A validation study.

M. Nielen, J. Kirpensteijn, O. Klungel, 2016, Preventive veterinary medicine.

In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers.

C. Rodriguez, R. Rebhun, S. Al-Nadaf, 2018, Veterinary and comparative oncology.

Retrospective Evaluation of Acute Kidney Injury After Zoledronic Acid Administration to Dogs With Malignant Osteolysis

J. Burton, K. Skorupski, C. Palm, 2021, Frontiers in Veterinary Science.

Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma.

D. Thamm, S. Dow, L. Mitchell, 2011, Journal of veterinary internal medicine.

Population pharmacokinetics identifies rapid gastrointestinal absorption and plasma clearance of oral chlorambucil administered to cats with indolent lymphoproliferative malignancies.

S. Al-Nadaf, J. Burton, K. Skorupski, 2022, American journal of veterinary research.

NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma

James H. Doroshow, Amy LeBlanc, Yves Pommier, 2018, Clinical Cancer Research.

Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamide

R. Rebhun, S. Stanley, J. Burton, 2017, Veterinary and comparative oncology.

BCL2 and MYC are expressed at high levels in canine diffuse large B‐cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy

Paul R. Avery, S. Lana, C. Frank, 2017, Veterinary and comparative oncology.

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats

J. Rossmeisl, S. Dow, D. Vail, 2021, Veterinary and comparative oncology.

Association of cancer-related mortality, age and gonadectomy in golden retriever dogs at a veterinary academic center (1989-2016)

R. Rebhun, M. Kent, D. Bannasch, 2018, PloS one.

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

T. Fan, S. Suter, C. Khanna, 2021, Clinical Cancer Research.

Regulatory T cells in canine cancer

J. Burton, 2007 .

Evaluation of Accuracy for 18 F-FDG Positron Emission Tomography and Computed Tomography for Detection of Lymph Node Metastasis in Canine Oral Malignant Melanoma.

K. Woolard, M. Giuffrida, A. Zwingenberger, 2020, Veterinary and comparative oncology.

Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs

R. Rebhun, S. Al-Nadaf, J. Burton, 2022, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Gender Imbalance in Authorship of Veterinary Literature: 1995 versus 2015.

M. Giuffrida, J. Dechant, J. Burton, 2019, Journal of veterinary medical education.

Procedural description and prospective evaluation of short-term outcome for the use of prostatic artery embolization in dogs with carcinoma of the prostate.

C. Rodriguez, R. Rebhun, M. Giuffrida, 2021, Journal of the American Veterinary Medical Association.

A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model

Christina Mazcko, Amy K. LeBlanc, Jessica Lawrence, 2016, PloS one.

High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy.

K. Woolard, R. Rebhun, S. Al-Nadaf, 2023, Journal of the American Animal Hospital Association.

A multi-institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma.

Shirley Chu, J. Bryan, Suhwon Lee, 2023, Veterinary and comparative oncology.

The role of clinical trials in veterinary oncology.

C. Khanna, J. Burton, 2014, The Veterinary clinics of North America. Small animal practice.

Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.

B. Powers, J. Burton, B. Biller, 2014, Veterinary and comparative oncology.